While evidence on the product may be limited while still in development, health economic models can provide insights to guide your strategic planning during development. Capitalizing on the available (limited) clinical experiences, relevant literature and expert opinions, early decision models are designed for you to easily explore alternative scenarios. These investigations can be used to support clinical trial design, product positioning, pricing strategies and target product profile evaluations. Sensitivity and value of information analyses can also help focus your outcomes research efforts to decrease uncertainty in the final models prior to commercialization. Thus, early decision models developed by CHEORS can play a crucial role in informing a wide range of strategic decisions during development of the technology. Because we understand both the technical aspects of model development and how they can be used to inform strategic decisions made during development, CHEORS is uniquely positioned to partner with you in taking advantage of early decision models
“Thank you for this. This is great work!”
Principal Scientist,
Biopharmaceutical Company“I am very happy working with the CHEORS team. CHEORS stands out in particular in the area of communication and responsiveness. I always feel assured that there is no misunderstanding.”
Assoc. Director,
Biopharmaceutical Company“I am most pleased to work with CHEORS. We managed early deadlines with high-quality end results.”
Specialist,
Outcomes Research/Medical Affairs"With aspect of technical knowledge, communication and responsiveness, CHEORS is fantastic. I am very happy with your work. Frankly, you have over-delivered than what I expected"
HTA Manager,
Biopharmaceutical Company“CHEORS is experienced and found solutions to all issues we faced during the preparation time. Communication was very precise and strict—we were happy to work with the team.”